Table 4.

Effects of the WL and AEX+WL interventions stratified by glucose tolerance status

	WL		AEX+WL		Intervention *Group	Intervention	Group
	NGT (N=15)	IGT (N=13)	NGT (N=20)	IGT (N=12)
ΔBody weight (kg)	−6.5 ± 0.7‡	−7.7 ± 0.9‡	−7.2 ± 0.7‡	−7.4 ± 1.4‡	NS	NS	NS
BMI (kg/m2)	−2.4 ± 0.3‡	−2.9 ± 0.3‡	−2.7 ± 0.2‡	−2.7 ± 0.5‡	NS	NS	NS
ΔWaist circumference (cm)	−5.9 ± 1.6‡	−5.9 ± 1.4‡	−4.4 ± 1.1‡	−4.4 ± 1.7†	NS	NS	NS
ΔHip circumference (cm)	−5.7 ± 0.9‡	−4.6 ± 1.5‡	−5.2 ± 1.3‡	−7.0 ± 1.4‡	NS	NS	NS
ΔWHR	−0.01 ± 0.01	−0.01 ± 0.01	0.01 ± 0.01	0.00 ± 0.02	NS	NS	NS
ΔBody fat (%)	−2.1 ± 0.4‡	−3.0 ± 0.6‡	−4.6 ± 0.7‡	−3.1 ± 1.1‡	NS	NS	NS
ΔTotal body fat mass (kg)	−4.9 ± 0.6‡	−6.5 ± 0.7‡	−6.4 ± 0.7‡	−5.8 ± 1.5‡	NS	NS	NS
ΔTotal body fat-free mass (kg)	−1.6 ± 0.5‡	−2.4 ± 1.0†	−0.6 ± 0.3	−1.0 ± 1.0	NS	<0.05	NS
ΔAndroid fat mass (kg)	−0.42 ± 0.10‡	−0.65 ± 0.10‡	−0.61 ± 0.07‡	−0.55 ± 0.14‡	NS	NS	NS
ΔGynoid fat mass (kg)	−0.97 ± 0.16‡	−1.10 ± 0.13‡	−1.29 ± 0.17‡	−1.03 ± 0.21‡	NS	NS	NS
ΔAndroid/gynoid fat mass	0.002 ± 0.010	−0.007 ± 0.009	−0.020 ± 0.006‡	−0.014 ± 0.010	NS	<0.05	NS
ΔVisceral abdominal fat area (cm2)	−20.3 ± 11.9	−23.5 ± 8.1†	−20.3 ± 5.9‡	−25.6 ± 15.5	NS	NS	NS
ΔSubcutaneous abdominal fat area (cm2)	16.6 ± 51.1	−61.70 ± 29.0	−77.2 ± 15.1‡	−68.4 ± 18.5†	NS	NS	NS
ΔVisceral/subcutaneous abdominal fat area	−0.09 0.09	0.05 0.07	−0.01 0.02	−0.03 0.02	NS	NS	NS
ΔAbsolute VO2max (L/min)	−0.10 ± 0.06	−0.03 ± 0.04	0.21 ± 0.04‡	0.19 ± 0.06‡	NS	<0.01	NS

Significant change from baseline:

^†P<0.05,

^‡P<0.01.

Intervention represents WL vs. AEX+WL; Group represents NGT vs. IGT.